The U. S. Food and Drug Administration (FDA) has given green signal to BioDelivery Sciences International (BDSI) for a new drug application for BunavailT buccal film.
Bunavail is used for maintenance treatment of opioid dependence. It comprises of a film that sticks to the inside of the cheek. It uses an advanced drug delivery technology that allows patients to talk, swallow and carry on with daily activities while the medication is absorbed slowly.
Also read: At least 25 dead in Sumatra earthquake